Market cap
$62.4m
End-of-day close multiplied by current shares on issue.
Operating cash flow turned positive, yet $3.9m of Munroe Lane capex cut cash holdings by $4.0m and left NTA per share at $0.307.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$62.4m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.01
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
0.56x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
4.7%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY26 vs FY25
Revenue
$6.6m
-3.8% ↓ vs $6.8m
Net profit after tax
−$3.2m
+43.9% ↑ vs −$5.7m
Net cash inflow from operating activities
$3.1m
n/m ↑ vs −$0.14m
Final dividend per share
0.2c
flat vs 0.2c
Profit before tax
−$3.6m
+36.8% ↑ vs −$5.7m
Cash and cash equivalents
$6.9m
-36.6% ↓ vs $10.9m
Total assets
$113m
-4.3% ↓ vs $118m
What changed
Capital expenditure on investment properties stepped up to NZ$3.9m, versus NZ$0.1m the prior year, primarily on Munroe Lane.
Cash holdings fell NZ$4.0m to NZ$6.9m. Total assets closed at NZ$113.0m, sitting below Annolyse's historical baseline of NZ$190.6m, which reflects the FY25 disposal of 35 Graham Street and the associated debt repayment. NTA per share fell 5.2% to NZ$0.307 as equity declined NZ$6.1m on the FY26 loss. PBT and NPAT losses narrowed in absolute terms, though a basis-discontinuity caveat from the portfolio change limits clean growth-rate comparison.
What matters
FFO of NZ$3.2m and AFFO of NZ$0.2m, with OCF of NZ$3.1m, mark a clear step-up versus the transitional FY25. For a property issuer, FFO is the cleaner cash-earnings read than statutory profit, and FY26 is the first full year since external bank debt was repaid.
Capex absorbed all operating cash and more. Spend of NZ$3.9m equaled 59.3% of revenue and exceeded both FFO and OCF. Pre-lease free cash flow was NZ$-0.8m — far better than the historical baseline mean of NZ$-25.0m, but still negative — and cash declined to NZ$6.9m, narrowing the buffer for further development without external funding.
Book value is still drifting lower despite the cash inflection. Equity fell NZ$6.1m on the FY26 loss, taking NTA per share down 5.2% to NZ$0.307. The accounting loss sitting above the FFO line implies fair-value or non-cash charges are diluting book value even as cash earnings recover.
Expectations
Second-half shape is unusually skewed: HY26 reported a NZ$1.6m profit, and the full-year NZ$3.2m loss implies an H2 loss of roughly NZ$4.8m, indicating that the bulk of the FY26 fair-value or other non-cash charges landed in the second half rather than spreading evenly.
Occupancy at 75.6% includes the unconditional MILK Orthodontics lease, which is yet to commence. That leaves rental income with disclosed upside once the tenancy is income-generating. Without forward income, AFFO, or distribution targets, the read on FY27 has to come from occupancy progression, Munroe Lane capex run-off, and the next valuation cycle rather than from disclosed guidance.
Quality of result
Debtor days at 0.6 sit at the lower edge of the supplied historical range, working-capital movement is neutral and within Annolyse's historical baseline, and the OCF swing is driven by the rental portfolio rather than a one-off working-capital release. That supports treating the FFO line as recurring rather than timing-assisted.
What does not look durable in the headline is the NPAT outcome, which is heavily shaped by the implied H2 charge not visible in revenue or cash. The FCF-to-NPAT ratio of 25.5% is mathematically improved but reflects two losses rather than a healthy conversion. The effective tax rate moved to 12.2% from 0.0%, contributing to a NZ$0.4m gap between PBT and NPAT outcomes; both PBT-growth and NPAT-growth categories carry a basis-discontinuity caveat from the 35 Graham Street disposal, so absolute-dollar improvement is the cleaner read than percentage growth. The NZ$4.0m cash drawdown to fund capex means liquidity, not earnings, is the binding constraint.
Unresolved
This briefing cannot assess the underlying property valuations, lease economics, or Munroe Lane cost-to-completion that would determine whether the FFO step-up extends into FY27.
Chat
Ask follow-up questions about Asset Plus's FY26 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
Asset Plus company filing
FY26 / results announcementAsset Plus company filing
FY26 / results releaseAsset Plus FY26 Annual Report
FY26 / financial reportAsset Plus FY26 Results Presentation
FY26 / results presentationAsset Plus FY25 Annual Report
FY25 / financial reportAsset Plus FY25 Annual Results Presentation
FY25 / results presentationcompany filing
FY25 / results announcementcompany filing
FY25 / results releaseAsset Plus FY26 Interim Financial Statements
HY26 / financial reportAsset Plus FY26 Interim Results Presentation
HY26 / results presentationAsset Plus FY26 NZX Interim company filing
HY26 / results announcementAsset Plus FY26 NZX Interim Results Release
HY26 / results releaseAsset Plus - Annual results conference call details
FY25 / commentaryAsset Plus NZX Release - FY26 Results Date and Conference Call details
FY26 / commentary2025 AGM Presentation
HY26 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 7.8pp, with a distortion flag in the result.
Revenue growth context
Revenue growth was -3.8% for this reporting period.
ROE and capital efficiency
ROE was -2.8%, +2.0pp versus the prior comparable period.
Working-capital pressure
Debtor days were 1 days for this result.
Get the next Asset Plus briefing and related NZX reporting-season updates by email.